Abstract
The acute inflammatory response consists of three main vascular effects: vasodilatation and increased blood flow, increased vascular permeability, and leucocytosis into the injured tissues. All three events are induced relatively quickly, and, for all three, the pattern of response is complex but consistent. The characteristic increase of vascular permeability may be monophasic, diphasic or even triphasic. These various patterns of response may nevertheless be ‘dissected’ into three main types of responses: viz., (1) immediate, (2) delayed and (3) early, each of which may occur alone or in various combinations. The problem of mediation, therefore, becomes one of defining the mechanisms underlying each type of response. Immediate responses are usually mediated by histamine and/or 5-hydroxytryptamine. Delayed responses seem to result from pharmacological mediation although the corresponding factors remain unidentified. Early responses seem mainly due to disruption of endothelium, to which is added a small contribution by pharmacological mediation. Evidence will be presented to support the role of kinins as mediators of the delayed response. The evidence mainly arises from recent work illustrating that histamine induces refractoriness of susceptible blood vessels and so can evoke only a short-lived response, whereas kinins induce no such refractoriness and could, therefore, mediate the relatively prolonged responses obtained in delayed-type effects.
The paper will conclude by attempting to answer four questions:
-
(1)
Why does the pattern of the permeability response often exhibit an intermediate interval of normal low permeability?
-
(2)
Why may erythema be so prominent at a stage when the corresponding permeability effects are minimal?
-
(3)
What is the relation of local tissue leucocytosis to the delayed permeability effects induced by injury?
-
(4)
Nearly all our knowledge of the permeability response in experimental injury is restricted to the events in skin, to less extent in muscle and serous cavities. Are the permeability responses similar in other tissues and organs?
Similar content being viewed by others
References
F. Allison andM.G. Lancaster, Br. J. exp. Path.40, 324 (1959).
A. Baumgarten andD. L. Wilhelm, Pathology1, 301 (1969).
A. Baumgarten, G.J.H. Melrose andW.J. Vagg, Experientia23, 884 (1967).
A. Baumgarten, G.J.H. Melrose andW.J. Vagg, Dermatologica140, 219 (1970a).
A. Baumgarten, G.J.H. Melrose andW.J. Vagg, J. Physiol., Lond.208, 669 (1970b).
J.F. Burke andA.A. Miles, J. Path. Bact.76, 1 (1958).
J. Carr andD.L. Wilhelm, Aust. J. exp. Biol. med. Sci.42, 511 (1964).
J. Carr andD.L. Wilhelm, Nature, Lond.208, 653 (1965).
R.S. Cotran, Am. J. Path.46, 589 (1965).
R.S. Cotran, Lab. Invest.17, 39 (1967).
R.S. Cotran andG. Majno, Am. J. Path.45, 261 (1964).
R.S. Cotran andM.A. Pathak, J. invest. Derm.51, 155 (1968).
R.S. Cotran andJ.P. Remensnyder, Ann. N.Y. Acad. Sci.150, 495 (1968).
R.S. Cotran, E. R. Suter andG. Majno Vasc. Dis.4, 107 (1967).
J.P. Craig, in:Proceedings of the Cholera Research Symposium (EdsO.A. Bushnell andC.S. Brookhyser; US Government Printing Office, Washington, D.C. 1965), p. 153–158.
J.P. Craig andA.A. Miles, J. Path. Bact.81, 481 (1961).
R. Cummings andA.W.J. Lykke, Br. J. exp. Path.51, 19 (1970).
R. Cummings andA.W.J. Lykke, Pathology5, 117 (1973).
J.M. Elder andA.A. Miles, J. Path. Bact.74, 133 (1957).
W.P. Faulk, H. Snippe andK.W. Pondman, Immunology21, 489 (1971).
M. Greaves andS. Shuster, J. Physiol., Lond.193, 255 (1967).
G. Logan andD.L. Wilhelm, Br. J. exp. Path.47, 286 (1966a).
G. Logan andD.L. Wilhelm, Br. J. exp. Path.47, 300 (1966b).
A.W.J. Lykke andR. Cummings, Br. J. exp. Path.50, 309 (1969).
A. W. J. Lykke, D. A. Willoughby andE. R. Kosche, J. Path. Bact.94, 381 (1967).
G. Majno, in:Injury, Inflammation and Immunity (EdsL. Thomas, J.W. Uhr andL. Grant; Williams and Wilkins Co., Baltimore 1964), p. 58–93.
G. Majno, in:Handbook of Physiology (Am. Physiol. Soc.), vol. 3, sect. 2 (Ed. J. Field; Williams and Wilkins Co., Baltimore 1965), p. 2293–2375.
G. Majno andG.E. Palade, J. biophys. biochem. Cytol.11, 571 (1961).
G. Majno, S.M. Shea andM. Leventhal, J. cell. Biol.42, 647 (1969).
S. Mellander andB. Johansson, Pharmac. Rev.20, 117 (1968).
A.A. Miles andE.M. Milles, J. Physiol., Lond.118, 228 (1952).
A.A. Miles andD.L. Wilhelm, in:The Biochemical Response to Injury (Ed. H.B. Stoner; Pergamon, Oxford 1960), p. 51–79.
J. F. Mustard, H.Z. Movat, D.R.L. Macmorine andA. Sényi, Proc. Soc. exp. Biol.119, 988 (1965).
S.G. Ramsdell, J. Immun.15, 305 (1928).
L.J. Rather, Bull. N.Y. Acad. Med.47, 303 (1971).
R.A. Rawson, Am. J. Physiol.138, 708 (1943).
M. Rocha e Silva, Ann. N.Y. Acad. Sci.116, 899 (1964).
S. Sevitt, J. Path. Bact.75, 27 (1958).
S. Sevitt, in:Injury, Inflammation and Immunity (Eds L. Thomas, J.W. Uhr and L. Grant; Williams and Wilkins Co., Baltimore 1964), p. 183–210.
W.G. Spector, J. Path. Bact.72, 367 (1956).
R.H. Steele andD.L. Wilhelm, Br. J. exp. Path.47, 612 (1966).
R.H. Steele andD.L. Wilhelm, Br. J. exp. Path.48, 592, (1967).
R.H. Steele andD.L. Wilhelm, Br. J. exp. Path.51, 265 (1970).
F.R. Wells andA.A. Miles, Nature, Lond.200, 1015 (1963).
D.L. Wilhelm, in:Inflammation, Biochemistry and Drug Interaction (Eds A. Bertelli and J.C. Houck; Excerpta Medica Foundation, Amsterdam 1969), p. 136–144.
D. L. Wilhelm, Rev. can. Biol.30, 153 (1971).
D. L. Wilhelm, in:The Inflammatory Process, 2nd ed., vol. 2 (Eds B.W. Zweifach, L. Grant and R.T. McCluskey; Academic Press, New York 1973), p. 251–301.
D.L. Wilhelm andB. Mason, Br. med. J.2, 1141 (1958).
D.L. Wilhelm andB. Mason, Br. J. exp. Path.61, 487 (1960).
D.A. Willoughby andJ.P. Giroud, J. Path.98, 53 (1969).
K. Wilms-Kretschmer, M. Flax andR.S. Cotran, Lab. Invest.17, 334 (1967).
Author information
Authors and Affiliations
Additional information
Supported by research grants from the National Health and Medical Research Council of Australia, and the Asthma Foundation of New South Wales.
Rights and permissions
About this article
Cite this article
Wilhelm, D.L. Mechanisms responsible for increased vascular permeability in acute inflammation. Agents and Actions 3, 297–306 (1973). https://doi.org/10.1007/BF01986484
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01986484